Efficacy and safety of sacubitril/valsartan compared with olmesartan in Asian patients with essential hypertension: A randomized, double‐blind, 8‐week study-Reference-Cited by-同舟云学术

Efficacy and safety of sacubitril/valsartan compared with olmesartan in Asian patients with essential hypertension: A randomized, double‐blind, 8‐week study

Published:2018-12-11 Issue: Volume: Page:
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J Clin Hypertens

Author:

Huo Yong¹^ORCID,Li Weimin²,Webb Randy³,Zhao Li⁴,Wang Qian⁵,Guo Weinong³

Affiliation:

1. Department of Cardiology Peking University First Hospital Beijing China

2. The 1st Affiliated Hospital of Harbin Medical University Harbin China

3. Novartis Pharmaceuticals Corporation East Hanover New Jersey

4. Novartis Pharmaceuticals Corporation Beijing China

5. Novartis Pharmaceuticals Corporation Shanghai China

Funder

Novartis Pharmaceuticals Corporation

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jch.13437

Reference38 articles.

1. Blood pressure and the global burden of disease 2000. Part 1: Estimates of blood pressure levels

2. Asia Pacific Cohort Studies C. Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysis;Lawes CM;Hypertension,2003

3. Systolic hypertension: an increasing clinical challenge in Asia

4. Cardiovascular Disease and Risk Factors in Asia

5. The burden of blood pressure‐related disease: a neglected priority for global health;Perkovic V;Hypertension,2007

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Sacubitril/Allisartan for the Treatment of Primary Hypertension;JACC: Asia;2024-09

2. Clinical Benefit of Sacubitril/Valsartan for Hypertensive Patients in Daily Practice and Predictors of Its Antihypertensive Effect;Circulation Reports;2024-07-10

3. Efficacy and Safety of Sacubitril/Valsartan in Adverse Cardiovascular Event Reduction and Hypertension Control Among Asians: A Systematic Review and Meta-analysis of Randomized Controlled Trials;Philippine Journal of Cardiology;2024-06-15

4. Efficacy of angiotensin receptor blockers for nocturnal blood pressure reduction: a systematic review and meta-analysis;Annals of Medicine;2024-06-03

5. Comparison of sacubitril/valsartan with olmesartan for hypertension: A meta-analysis of randomized controlled trials;Medicine;2024-04-05